SCHEMBL6571673

SCHEMBL6571673

CC=Cc1ccc2ncccc2c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
MAPT P10636 4/20 0.52
ERN1 O75460 3/20 0.47
CYP3A4 P08684 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 2/20 0.42
HSP90AA1 P07900 2/20 0.42
HSP90AB1 P08238 1/20 0.42
BLM P54132 1/20 0.42
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
NPC1 O15118 1/20 0.40
IDO1 P14902 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6571662 1.00 KDM4E (0.52) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL11652810 0.80 MAPT (0.54) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL29951440 0.78 ERN1 (0.64) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL5541894 0.76 MAPT (0.58) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL3155534 0.75 KDM4E (0.62) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL8537074 0.74 PTPN22 (0.50) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL10337519 0.74 ESR1 (0.41) KDM4EMAPTERN1HTTNPC1
SCHEMBL8537080 0.74 PTPN22 (0.50) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL29955571 0.74 MAPT (0.56) KDM4EMAPTERN1CYP3A4MEN1
SCHEMBL13351489 0.74 MAPT (0.62) KDM4EMAPTCYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432694-A1 STEREOSPECIFIC PROCESS FOR THE SYNTHESIS OF 2-YL CHROMAN DERIVATIVES Wyeth (US) 2004-06-30 EP disclosed
US-6716998-B2 SUCH AS (2R)-3,4-DIHYDRO-2H-CHROMEN-2-YL-METHYL-4-METHYL-BENZENESULFONATE; METATHESIS RING CLOSING POLYMERIZATION WYETH 2004-04-06 US disclosed
US-20030100774-A1 Process for synthesis of 2-yl chroman derivatives WYETH (US) 2003-05-29 US disclosed
WO-2003031428-A1 STEREOSPECIFIC PROCESS FOR THE SYNTHESIS OF 2-YL CHROMAN DERIVATIVES WYETH (US) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100774-A1 Process for synthesis of 2-yl chroman derivatives CDYL, CDY1; CDY1B, CDYL2 KDM4E 112/4885MAPT 4517/4885ERN1 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.